Key facts
- Pharma Green Holding’s last known valuation is $146.2M (Jul 2025).
- It has raised $43.9M; the latest was PE Growth/Expansion ($11.7M) in Jul 2025.
- Notable investors include Eurizon Capital Real Asset SGR, Heritage Group (Monaco), ISA (Pharmacueticals), L'Erbolario, UnipolSai Assicurazioni.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Pharma Green Holding
- ·The full record, as it builds
Funding rounds
No funding rounds for Pharma Green Holding are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pharma Green Holding
Operator of a chain of pharmacy companies intended to bring together and integrate with the national health service. The company has a network of pharmacists and specialized consultants, grounded in science and technology along with investing in specialization and professional training tools, thereby minimizing our impact on the environment by optimizing processes, reducing waste and choosing sustainable partners, products and materials.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Milan, Italy
- Founded
- 2021
- Employees
- 430
- Website
- pharma-green.it/
- Ownership
- Privately Held (backing)
Pharma Green Holding doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pharma Green Holding shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pharma Green Holding in its N-PORT filings yet. We sweep new filings monthly.